Optimize drug therapy and monitor patient adherence.
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Sun, Tue, Thu
Serum Pre-dose (Trough) Draw - At a Steady State Concentration or Plasma Pre-dose (Trough) Draw - At a Steady State Concentration in Plain Red, Lavender (K2EDTA), Lavender (K3EDTA), or Pink (K2EDTA).
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Whole blood. Gel Separator Tubes, Light Blue (Sodium Citrate), or Yellow (SPS or ACD Solution).
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 months
|Carisoprodol, Serum or Plasma||Less than 8.0 µg/mL
Toxic: Greater than or equal to 8.0 µg/mL
|Meprobamate, Serum or Plasma||
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. Adverse effects may include drowsiness, dizziness and headache.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
80369 (Alt code: G0480)
|Component Test Code*||Component Chart Name||LOINC|
|2011455||Carisoprodol, Serum or Plasma||3437-1|
|2011456||Meprobamate, Serum or Plasma||3753-1|
- Carisoprodol and Metabolite
- Soma Compound